Screener
Vera Therapeutics VERA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $13,909 | $21,898 |
| Accrued expenses and other liabilities, current | 31,240 | 31,557 |
| Total current liabilities | 45,149 | 53,455 |
| Long-term debt | 75,029 | 74,838 |
| Other liabilities, noncurrent | 1,864 | 1,919 |
| Total liabilities | 122,042 | 130,212 |
| Stockholders’ equity |
Item 1. Financial Statements
FAQ
- What is Vera Therapeutics's total current liabilities?
- Vera Therapeutics (VERA) reported total current liabilities of $45.15M in Q1 2026.
- How has Vera Therapeutics's total current liabilities changed year-over-year?
- Vera Therapeutics's total current liabilities increased by 106.2% year-over-year, from $21.89M to $45.15M.
- What is the long-term trend for Vera Therapeutics's total current liabilities?
- Over 5 years (2020 to 2025), Vera Therapeutics's total current liabilities has grown at a 85.9% compound annual growth rate (CAGR), from $2.41M to $53.46M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Vera Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude